Effects of Cytochrome P450 3A4 Inhibitors-Ketoconazole and Erythromycin-on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling Predictions. (Q53360959)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effects of Cytochrome P450 3A4 Inhibitors-Ketoconazole and Erythromycin-on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling Predictions.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

Effects of Cytochrome P450 3A4 Inhibitors-Ketoconazole and Erythromycin-on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling Predictions. (English)

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

author name string

Christophe Boetsch

1

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

Neil Parrott

2

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

Stephen Fowler

3

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

Agnes Poirier

4

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

Dominik Hainzl

5

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

Ludger Banken

6

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

Meret Martin-Facklam

7

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

Carsten Hofmann

8

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

publication date

1 February 2016

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

55

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

237-247

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

2

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

https://scigraph.springernature.com/pub.10.1007/s40262-015-0312-0

0 references

The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Physiologically based pharmacokinetic modelling to predict single- and multiple-dose human pharmacokinetics of bitopertin

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Quantitative correlations among CYP3A sensitive substrates and inhibitors: literature analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Adverse effects of macrolide antibacterials

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

The human intestinal cytochrome P450 "pie".

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Stochastic prediction of CYP3A-mediated inhibition of midazolam clearance by ketoconazole

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

The effects of grapefruit juice on the pharmacokinetics of erythromycin

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Prediction of the effect of erythromycin, diltiazem, and their metabolites, alone and in combination, on CYP3A4 inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Influence of solute carriers on the pharmacokinetics of CYP3A4 probes.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Scientific perspectives on drug transporters and their role in drug interactions

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Membrane transporters in drug development

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Calibration of in vitro multidrug resistance protein 1 substrate and inhibition assays as a basis to support the prediction of clinically relevant interactions in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

Physiologically based absorption modelling to predict the impact of drug properties on pharmacokinetics of bitopertin

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0312-0

21 January 2018

World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/26341813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ketoconazole and the modulation of multidrug resistance-mediated transport in Caco-2 and MDCKII-MDR1 drug transport models

1 reference

https://pubmed.ncbi.nlm.nih.gov/26341813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the intestinal absorption of erythromycin in man: absolute bioavailability and comparison with enteric coated erythromycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/26341813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New strategies to address drug-drug interactions involving OATPs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26341813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40262-015-0312-0

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

release_gt2qdbpkgvfidgep3sguyvgczu

1 reference

https://api.fatcat.wiki/v0/release/gt2qdbpkgvfidgep3sguyvgczu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/26341813

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53360959&oldid=1842922540"